Monmouth County, N.J., Doctor Pleads Guilty To Oxycodone Distribution And Conspiracy
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Monmouth County, N.J., Doctor Pleads Guilty To Oxycodone Distribution And Conspiracy

Monmouth County, N.J., Doctor Pleads Guilty To Oxycodone Distribution And Conspiracy

Octubre 22, 2012
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

TRENTON, N.J. - Robert G. Koval, Acting Special Agent in Charge of the New Jersey Division of the Drug Enforcement (DEA) and Paul J. Fishman, the United States Attorney for the District of New Jersey, announced a doctor who allegedly wrote illegal prescriptions for oxycodone, today admitted to participating in a conspiracy to distribute the medication illegally.

Jacqueline Lopresti, 52, of Fair Haven, N.J., pleaded guilty before Judge Freda L. Wolfson to an Information charging her with one count of conspiracy to distribute oxycodone and 11 counts of distribution of oxycodone.

According to documents filed in this case and statements made in court:

Oxycodone is the active ingredient in brand name pills such as Oxycontin, Roxicodone and Percocet. It is a Schedule II controlled substance - meaning that it has a high potential for abuse. It has a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

In 2009, Lopresti issued prescriptions to co-conspirators for drugs containing oxycodone, outside the usual course of medical practice and not for any legitimate medical purpose. The prescriptions were filled at various pharmacies located in and around Monmouth, Ocean, and Atlantic counties, N.J., and redistributed by others.

The charge to which the defendant pleaded guilty is punishable by a maximum potential penalty of 20 years in prison and a $1 million fine. Sentencing is scheduled for Jan. 30, 2013. U.S. Attorney Fishman credited the N.J. DEA Tactical Diversion Squad, composed of DEA special agents, diversion investigators and intelligence analysts; FBI and IRS special agents; and local law enforcement officers from the Essex County Sheriff’s Bureau of Narcotics, Newark Police Department, Elizabeth Police Department, Clinton Township Police Department, and Somerset County Prosecutor’s Office.

The government is represented by Assistant U.S. Attorney R. Joseph Gribko of the U.S.
Attorney’s Office in Trenton.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Cheryl Ortiz, Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español